Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)’s Institute for Psychedelic Research ...
Authorized to sell psilocybin through Health Canada's Special Access Program. "Receiving this licence is a significant achievement for APEX alongside our tremendous progress actively dosing patients ...
Apex Labs CBD recently announced its entrance into a new frontier in delivery methods of cannabinoids—intravenous (IV) therapy—by pioneering a first-of-its-kind solution with patent-pending technology ...
VANCOUVER, BC, March 7, 2024 /CNW/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the filing of ...
An American laboratory specializing in home phlebotomy has disclosed a cyber-attack that occurred five months ago after data stolen in the attack turned up online. Apex Laboratory opened in 1997 and ...
The investment aligns with SGC’s strategy of partnering with U.S.-based manufacturing businesses where operational excellence, disciplined execution, and strategic acquisitions can drive sustainable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results